Synapse - David Scheinberg

Results (19)

Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy

Meeting Abstract

Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR)

Meeting Abstract

Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma

Meeting Abstract

Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
Blood (2016)

Fulltext@MSK | Save

CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes through cytokine feed forward mechanisms

Meeting Abstract

Mathias, M. D.; Sockolosky, J. T.; Chang, A. Y. Y.; Liu, C.; Garcia, K. C.; Scheinberg, D. A.
Blood (2016)

Fulltext@MSK | Save

Phase I trial of targeted alpha-particle therapy with Actinium-225 ((225)Ac)-lintuzumab and low-dose cytarabine (LDAC) in patients age 60 or older with untreated acute myeloid leukemia (AML)

Meeting Abstract

Jurcic, J. G.; Levy, M. Y.; Park, J. H.; Ravandi, F.; Perl, A. E.; Pagel, J. M.; Smith, B. D.; Estey, E. H.; Kantarjian, H.; Cicic, D.; more...
Blood (2016)

Fulltext@MSK | Save

Kinase regulation of human MHC class i molecule expression on cancer cells

Journal Article

Brea, E. J.; Oh, C. Y.; Manchado, E.; Budhu, S.; Gejman, R. S.; Mo, G.; Mondello, P.; Han, J. E.; Jarvis, C. A.; Ulmert, D.; more...
Cancer Immunology Research (2016)

Fulltext@MSK | Save

Acute myeloid leukaemia

Journal Article

Khwaja, A.; Bjorkholm, M.; Gale, R. E.; Levine, R. L.; Jordan, C. T.; Ehninger, G.; Bloomfield, C. D.; Estey, E.; Burnett, A.; Cornelissen, J. J.; more...
Nature Reviews Disease Primers (2016)

Fulltext@MSK | Save

CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes

Meeting Abstract

Mathias, M.; Sockolosky, J.; Chang, A.; Liu, C.; Garcia, K.; Scheinberg, D.
Clinical Lymphoma, Myeloma and Leukemia (2016)

Fulltext@MSK | Save

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Journal Article

Şenbabaoğlu, Y.; Gejman, R. S.; Winer, A. G.; Liu, M.; Van Allen, E. M.; de Velasco, G.; Miao, D.; Ostrovnaya, I.; Drill, E.; Luna, A.; more...
Genome Biology (2016)

Fulltext@MSK | Save

Remodeling the vascular microenvironment of glioblastoma with α-particles

Journal Article

Behling, K.; Maguire, W. F.; Di Gialleonardo, V.; Heeb, L. E. M.; Hassan, I. F.; Veach, D. R.; Keshari, K. R.; Gutin, P. H.; Scheinberg, D. A.; McDevitt, M. R.
Journal of Nuclear Medicine (2016)

Fulltext@MSK | Save